CN211156149U - Anti-adhesion tension-free uterine cavity conformal barrier - Google Patents
Anti-adhesion tension-free uterine cavity conformal barrier Download PDFInfo
- Publication number
- CN211156149U CN211156149U CN201921644391.5U CN201921644391U CN211156149U CN 211156149 U CN211156149 U CN 211156149U CN 201921644391 U CN201921644391 U CN 201921644391U CN 211156149 U CN211156149 U CN 211156149U
- Authority
- CN
- China
- Prior art keywords
- support
- uterine cavity
- tube
- adhesion
- drainage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
- 230000004888 barrier function Effects 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 claims description 52
- 238000002347 injection Methods 0.000 claims description 45
- 239000007924 injection Substances 0.000 claims description 45
- 239000007788 liquid Substances 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 210000003679 cervix uteri Anatomy 0.000 abstract description 32
- 230000006378 damage Effects 0.000 abstract description 13
- 208000027418 Wounds and injury Diseases 0.000 abstract description 12
- 208000014674 injury Diseases 0.000 abstract description 8
- 230000001681 protective effect Effects 0.000 abstract description 4
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 208000028685 Asherman syndrome Diseases 0.000 description 4
- 206010000210 abortion Diseases 0.000 description 4
- 231100000176 abortion Toxicity 0.000 description 4
- 201000001389 adhesions of uterus Diseases 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- 206010011409 Cross infection Diseases 0.000 description 3
- 241000521257 Hydrops Species 0.000 description 3
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004696 endometrium Anatomy 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 239000003364 biologic glue Substances 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
- 208000001951 Fetal Death Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010064091 Iatrogenic infection Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 201000004458 Myoma Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 231100000479 fetal death Toxicity 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
An anti-adhesion tension-free uterine cavity conformable barrier comprises a uterine cavity support and a diaphragm, wherein the uterine cavity support comprises a first support and a second support, the first support and the second support are arranged in a uterine shape, the bottom ends of the first support and the second support are connected, a gap is formed in the top ends of the first support and the second support, the first support and the second support are not connected, and the diaphragm is filled between the first support and the second support; the first support and the second support are both elastic supports. The utility model provides an in the suitable type protective screen of no tension palace chamber pass the cervix uteri again through the tight closure of clamp in the palace chamber support through external force and place the palace chamber, reduce the area of palace chamber support, can not produce the injury to the cervix uteri, place like when the palace intracavity, two elastic support spring out naturally and be palace type structure, place simply.
Description
Technical Field
The utility model relates to the field of medical equipment, specifically be an antiseized tension-free uterine cavity conformable barrier.
Background
The intrauterine adhesion is a pathological phenomenon of partial or total adhesion formed after the intrauterine membrane is damaged, such as uterine curettage after artificial abortion and drug abortion, uterine curettage after midterm induction or full term abortion, non-pregnancy uterine diagnostic curettage, hysteromyoma removal, submucosal myoma removal, hysteroscopy and the like all cause intrauterine adhesion, usually can cause abnormal menstruation, such as hypomenorrhea or amenorrhea and the like, and patients are easy to suffer from abortion, premature birth, ectopic pregnancy, fetal death, intrauterine implantation, placental adhesion and even infertility or intrauterine hematocele.
Many studies have achieved certain clinical results by combining the use of intrauterine devices (intrauterine devices, Foley catheter balloons, intrauterine balloon, etc.) with some drugs. There are still many problems: 1. the main problems of the intrauterine device are: the uterine cavity isolation area is not enough; the intrauterine device is wrapped by the recurrent adhesions and deformed, so that the intrauterine device is difficult to take out and the recurrence rate of the adhesions is high; aseptic inflammation occurs, which is not beneficial to the healing of endometrium; the mixture is placed and taken out for a plurality of times to form new damage. 2. Foley balloon catheter: the spherical structure is not in accordance with the shape of the uterine cavity, the wound surface cannot be fully isolated, and particularly the peripheral type adhesion with high recurrence rate; the spherical structure causes the local wound surface to be obviously pressed, influences the blood supply under the intima and is not beneficial to the regeneration of the intima; the catheter remains inside and outside the vagina, causing iatrogenic infections and patient discomfort, increasing the time of use of antibiotics; can be kept only for a short time, with the risk of increasing infection and affecting intimal growth remaining for a long time; the balloon pressure is not proper, the balloon can fall off when the pressure is small, and the patient can feel uncomfortable when the pressure is large, and meanwhile, the intimal repair is influenced. 3. Uterine cavity conformable balloon: the placement is complex, and the cervix uteri needs to be fully dilated; the catheter can not drain the effusion in the uterine cavity and can not inject anti-adhesion medicines into the uterine cavity; the catheter remains in the vagina, with the risk of infection and discomfort to the patient; the long-term retention can press the wound surface, which is not beneficial to regeneration and repair of the intima. The pressure of the balloon is relatively uniform, but the balloon pressure is not proper, the balloon can fall off when the pressure is small, and the pressure is large, so that the discomfort of a patient can be caused, and the intimal repair is influenced.
Chinese patent CN109157274A discloses an anti-adhesion uterine cavity stent and a use method thereof, the stent comprises a uterine cavity ring, the uterine cavity ring is in an inverted triangle shape and is separated end to end at the bottom end, the tail end of the uterine cavity ring extends downwards and gradually enlarges to form a cervical canal support arm, a liquid medicine channel is arranged in the uterine cavity ring and the cervical canal support arm, a medicine application opening communicated with the liquid medicine channel is formed on the surface of the uterine cavity ring, a medicine injection tube is connected to the bottom of the cervical canal support arm, and the medicine injection tube is communicated with the liquid medicine channel. Although this palace chamber support can carry out the medicine to palace intracavity portion and pour into, what this palace chamber support adopted is the closed palace chamber ring structure in upper portion, need pass the cervix before the operation and put into the palace intracavity with palace chamber support, but because palace chamber ring whole area is too big, be difficult for placing, can excessively expand the cervix when placing, easily cause the injury to the cervix, and palace chamber support among the prior art mostly all adopts the closed loop configuration in top, when placing, even adopt external force to step up palace chamber support, but because the annular inherent width in palace chamber support top, hardly reduce the area of palace chamber support, thereby lead to that palace chamber support is difficult for placing, push the palace intracavity through the cervix is hard during placing, cause great injury to the cervix.
SUMMERY OF THE UTILITY MODEL
The utility model discloses the technical problem that will solve lies in: because the annular inherent width in palace chamber support top, hardly reduce the area of palace chamber support to lead to the difficult place of palace chamber support, push the palace intracavity through the cervix is hard when placing, lead to the fact the condition of great injury to the cervix, provide the suitable type barrier in non-tension palace chamber of antiseized.
The utility model discloses a following technical means realizes solving above-mentioned technical problem:
an anti-adhesion tension-free uterine cavity conformable barrier comprises a uterine cavity support and a diaphragm, wherein the uterine cavity support comprises a first support and a second support, the first support and the second support are arranged in a uterine shape, the bottom ends of the first support and the second support are connected, a gap is formed in the top ends of the first support and the second support, the first support and the second support are not connected, and the diaphragm is filled between the first support and the second support;
the first support and the second support are both elastic supports.
During the use, the anti-adhesion tension-free uterine cavity conformal barrier of placing under the natural state is that the palace type structure is open, when need use anti-adhesion tension-free uterine cavity conformal barrier to place the palace chamber in preventing the palace chamber adhesion, adopt instruments such as pliers to carry the outer wall of first support and second support this moment, can inwards press first support and second support, finally make first support and second support closed, then, the pliers is carried the uterine cavity support and is sent into the uterine cavity through the cervix, the uterine cavity support passes through behind the internal orifice of cervix, the natural spring-open is the palace type.
The uterine cavity support in the tension-free uterine cavity conformable barrier is composed of two elastic supports, and the tops of the two supports are connected, so that the uterine cavity support is not in a closed annular structure, when the tension-free uterine cavity conformable barrier is placed, the uterine cavity support is clamped and closed through external force and then passes through a cervix to be placed in a uterine cavity, the area of the uterine cavity support is reduced, no injury is caused to the cervix, when the tension-free uterine cavity conformable barrier is placed in the uterine cavity, the two elastic supports naturally spring open to form a uterine structure, and the placement is simple.
Preferably, the utility model discloses tension-free palace chamber conformal protective screen still includes connecting tube, connecting tube set up and palace chamber support bottom, first support and second support are inside hollow structure, connecting tube is linked together with first support and second support inner chamber.
Furthermore, the first support and the second support are two tubular structures which are not communicated with each other, the connecting pipeline comprises a medicine injection pipe and a drainage pipe, the medicine injection pipe is communicated with the inner cavity of the first support, and the drainage pipe is communicated with the inner cavity of the second support.
Furthermore, first support and first support top all are equipped with the opening, a plurality of liquid medicine mouths have been seted up to first support lateral wall, a plurality of drainage liquid mouths have been seted up to second support lateral wall.
The utility model discloses in through setting up palace chamber support to hollow structure, and be connected with the pipeline in palace chamber support sub-unit and can extract the interior hydrops of palace chamber and regularly observe the interior condition of bleeding of palace chamber when regularly dosing to the palace intracavity wall, and through setting up two pipelines of injection pipe and drainage tube in the invention, will dose and the drainage divides two pipelines to go on alone, place cross infection, the safety in utilization degree is high. After the amount of exudate is reduced, the connecting tube exposed in the vagina is cut off, and the isolation barrier is positioned in the uterine cavity, so that the uterine cavity can be kept in for a long time, and the ascending infection probability is reduced until the intima is completely repaired.
Furthermore, control valves are arranged on the medicine injection tube and the drainage tube, and the bottoms of the medicine injection tube and the drainage tube are connected with an injector or a drainage bag.
Furthermore, injection pipe and drainage tube are flexible tensile pipe, injection pipe and drainage tube overlap respectively on the straightway of first branch pipe and on the straightway of second branch pipe, the pipe diameter of first branch pipe slightly is greater than injection pipe diameter, the pipe diameter of second branch pipe slightly is greater than drainage tube pipe diameter.
Furthermore, anti-skid lugs are arranged on the outer sides of the straight line section of the first branch pipe and the straight line section of the second branch pipe, and the medicine injection pipe and the drainage pipe are sleeved on the anti-skid lugs.
Through establishing first support and second support with injection pipe and drainage tube direct cover respectively on, simple to operate sets up the pipe diameter that injection pipe and drainage tube and is less than the branch pipe diameter, prevents that injection pipe and drainage tube from droing from the branch pipe, through set up skid proof block on the branch pipe, further improves the joint force between the pipeline, places and drops each other between the connecting tube, influences the result of use.
Furthermore, the near opening end of the support is in an arc-shaped bent shape, so that the opening ends of the first support and the second support are prevented from being directly contacted and abutted against the inner wall of the uterine cavity, and the corners of the opening ends are prevented from damaging the inner wall of the uterine cavity.
Further, the bottom ends of the first support and the second support are connected at an included angle of 30-60 degrees.
Further, the diaphragm is a non-absorbent latex film or an absorbent biological film, the diaphragm is matched with the internal shape of the uterine cavity support, and two sides of the diaphragm are clamped in the two branch tubes.
The application also discloses a method for using the anti-adhesion tension-free uterine cavity conformal barrier, which is characterized by comprising the following steps:
(1) examining and evaluating the coronal plane of the uterine cavity before operation, and selecting a uterine cavity bracket with a proper size;
(2) after the hysteroscope intrauterine adhesion separation operation, sufficient hemostasis is realized, the hysteroscope bracket is closed by using a clamp, and the hysteroscope bracket naturally bounces open after passing through an inner opening to form a uterine shape;
(3) injecting anti-adhesion biological glue medicine into the connecting pipeline, discharging liquid through the connecting pipeline after half an hour, observing the liquid discharged from the uterine cavity and the bleeding condition, and keeping the observation for 7 days after the operation;
(4) exposing the cervix after 7 days, cutting off the catheter from the external opening of the cervix after pulling the connecting pipeline, retracting the catheter at the residual end into the cervix, and continuously keeping for 1-3 months;
(5) during hysteroscopy, the bottom of the uterine cavity support is clamped by an intravascular self-cervical tube inner clamp, the uterine cavity support is pulled and taken out, and then the hysteroscopy is carried out.
The utility model has simple use and convenient operation, and can not hurt the cervix or the uterine cavity.
The utility model has the advantages that:
1. the utility model provides a palace chamber support in tension-free palace chamber conformable barrier adopts two elastic support to constitute, because two support tops link to each other, palace chamber support is not a closed loop configuration, consequently when placing this application palace chamber conformable barrier, passes the cervix through the tight closure of clamp in the palace chamber support through external force and places the palace intracavity again, reduces the area of palace chamber support, can not produce the injury to the cervix, places like when the palace intracavity, two elastic support pop out naturally and be palace type structure, place simply.
2. The utility model discloses in through setting up palace chamber support to hollow structure, and be connected with the pipeline in palace chamber support sub-unit and can extract the interior hydrops of palace chamber and regularly observe the interior condition of bleeding of palace chamber when regularly dosing to the palace intracavity wall, and through setting up two pipelines of injection pipe and drainage tube in the invention, will dose and the drainage divides two pipelines to go on alone, place cross infection, the safety in utilization degree is high.
3. Through establishing first support and second support with injection pipe and drainage tube direct cover respectively on, simple to operate sets up the pipe diameter that injection pipe and drainage tube and is less than the branch pipe diameter, prevents that injection pipe and drainage tube from droing from the branch pipe, through set up skid proof block on the branch pipe, further improves the joint force between the pipeline, places and drops each other between the connecting tube, influences the result of use.
Drawings
FIG. 1 is a schematic view of the open state structure of the anti-adhesion tension-free uterine cavity conformable barrier of the present invention;
FIG. 2 is a schematic view of the closed state structure of the anti-adhesion tension-free uterine cavity conformable barrier of the present invention;
FIG. 3 is a schematic view of the structure of the uterine cavity stent of the present invention;
FIG. 4 is a schematic structural view of the anti-adhesion tensionless uterine cavity conformable barrier of the present invention located inside the uterine cavity;
fig. 5 is a schematic structural view (connecting pipe cut off) of the anti-adhesion tension-free uterine cavity conformable barrier of the present invention inside the uterine cavity;
the reference numbers illustrate:
1. a uterine cavity stent; 11. a first bracket; 111. a liquid medicine port; 12. a second bracket; 121-drainage liquid port; 13. an anti-slip bump; 2. a diaphragm; 3. connecting a pipeline; 31. a medicine injection tube; 32. a drainage tube; 33-control valve.
Detailed Description
To make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the embodiments of the present invention are combined to clearly and completely describe the technical solution in the embodiments of the present invention, and obviously, the described embodiments are some embodiments of the present invention, not all embodiments. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative efforts belong to the protection scope of the present invention.
Example one
As shown in fig. 1, including palace chamber support 1 and diaphragm 2, palace chamber support 1 includes first support 11 and second support 12, and first support 11 and second support 12 all include vertical section and elasticity section, and under the natural state, vertical section and elasticity section are certain contained angle, and the palace chamber support 1 that first support 11 and second support 12 formed is the Y form, and diaphragm 2 fills between two elasticity sections, and under the exogenic action, two elasticity section butts, form the columnar structure with two vertical sections.
When the uterine cavity conformable barrier is manufactured, the included angle and the size of the uterine cavity support 1 of the first support 11 and the second support 12 are Y-shaped, and the manufactured uterine cavity support 1 is manufactured according to the actual size of the uterine cavity, so that the shape and the size of the manufactured uterine cavity support 1 are suitable for the introduced uterine cavity structure.
Specifically, as shown in fig. 1, when in use, the anti-adhesion tensionless uterine cavity conformable barrier placed in a natural state is opened in a uterine structure, when the anti-adhesion tensionless uterine cavity conformable barrier is required to be placed in a uterine cavity to prevent the uterine cavity from adhering, the outer walls of the first support 11 and the second support 12 are clamped by using a tool such as a pliers, due to the elastic structure of the first support 11 and the second support 12, the elastic sections of the first support 11 and the second support 12 are pressed inwards under the action of the external force of the pliers, finally the first support 11 and the second support 12 are closed, the diaphragm 2 between the first support 11 and the second support 12 is folded, the closed state uterine cavity support 1 is in an approximate cylindrical structure as shown in fig. 2, then the pliers clamp clamps the uterine cavity support 1 to be delivered into the uterine cavity through the cervix, after the uterine cavity support 1 passes through the cervix, the uterine cavity support 1 naturally springs open to be in a uterine shape, the uterine cavity support 1 drives the diaphragm 2 to open when bouncing open.
As shown in fig. 2, the first holder 11 and the second holder 12 in this embodiment are closed and formed in a cylindrical shape having a diameter of about 6mm in a closed state. However, when the uterine cavity stent is used in detail, the height and other dimensions of the uterine cavity stent 1 can be set according to the size of the uterine cavity, and are not limited in the size range.
The first stent 11 and the second stent 12 in this embodiment are made of elastic bio-plastic or silica gel, and the stents have suitable elasticity, so that the uterine shape can be maintained, and the intima and muscle layers of the side walls can not be pressed excessively. And the smooth curves of the outlines of the first support 11 and the second support 12 do not cause damage to the intima of the side wall, and when the stent is used in particular, a layer of biological lubricant such as a water-soluble glycerin layer and the like can be coated outside the stent, so that the smoothness of the stent is improved, the uterine cavity stent can pass through the cervix more easily, and the injury cannot be caused.
the utility model provides a palace chamber support in tension-free palace chamber conformity protective screen is through adopting two elastic support to constitute, because two support tops link to each other, palace chamber support is not a closed loop configuration, consequently when placing this application palace chamber conformity protective screen, passes the cervix through the tight closure of clamp in the palace chamber support through external force and places the palace intracavity again, reduces the area of palace chamber support, can not produce the injury to the cervix, places like when the palace intracavity, two elastic support pop out naturally and be palace type structure, place simply.
Compared with the uterine cavity balloon device: isolation can be achieved without filling the balloon; excessive pressure does not exist on the endometrium and the wound surface, so that blood supply and necrosis are influenced, and the growth of the endometrium is influenced; the periphery is fully isolated, particularly the middle and lower sections, and the shape of the uterine cavity is met;
example two
As shown in fig. 1, on the basis of the first embodiment, the tensionless uterine cavity conformable barrier of the present invention further comprises a connecting pipe 3;
the connecting pipeline 3 comprises a medicine injection pipe 31 and a drainage pipe 32;
The drug injection tube 31 is communicated with the inner cavity of the first bracket 11, and the drainage tube 32 is communicated with the inner cavity of the second bracket 11.
The medicine injection tube 31 and the drainage tube 32 are both provided with a control valve 33, and the bottoms of the medicine injection tube 31 and the drainage tube 32 are connected with a syringe or a drainage bag.
As shown in fig. 4, in detail, when the uterine cavity stent 1 is placed in a uterine cavity, the connecting pipeline 3 connected with the bottom 1 of the uterine cavity stent is also brought into the cervix by the corresponding part, according to the requirement, the anti-adhesion glue and other medicines are injected into the medicine injection tube 31 by the syringe, under the action pressure of the syringe, the medicines enter the first stent 11 through the main tube 31, the medicine liquid flows into the inner wall of the uterine cavity through the plurality of medicine liquid ports formed on the side wall of the first stent 11 and the opening of the top end 11 of the first stent, the medicine liquid is uniformly released to the inner wall of the uterine cavity, the administration is completed, after the administration for a certain time, the accumulated liquid in the uterine cavity can be printed out through the drainage bag connected with the bottom of the drainage tube 32, the accumulated liquid sequentially enters the second branch tube 12 through the plurality of drainage liquid ports 121 on the second branch tube 12 or the opening at the top end of the second branch tube 12, and finally flows into the drainage bag connected with the uterine cavity, the infection or bleeding inside the uterine cavity can be observed through the effusion in the drainage bag. According to the observation condition, the liquid medicine can be injected into the inner wall of the uterine cavity through the medicine injection tube 31, and then the accumulated liquid is continuously pumped out through the drainage tube 32 for observation and inspection. As shown in fig. 5, after the administration and drainage are finished, the connecting tube 3 outside the cervix is cut off, and the catheter at the stub part is retracted into the cervix and is kept for 1-3 months.
In this embodiment, the control valves 33 may be respectively disposed on the drug injection tube 31 and the drainage tube 32, and the control valves 33 may control the inflow of the drug solution or the outflow of the effusion fluid.
The utility model discloses in through setting up palace chamber support 1 to hollow structure, and have the pipeline in palace chamber support 1 sub-unit connection can extract the interior hydrops of palace chamber and regularly observe the interior condition of bleeding of palace chamber when regularly dosing to the palace intracavity wall, and through setting up two pipelines of injection pipe and drainage tube in the invention, will dose and the drainage divides two pipelines to go on alone, places cross infection, and the safety in utilization is high. After the amount of exudate is reduced, the connecting tube exposed in the vagina is cut off, and the isolation barrier is positioned in the uterine cavity, so that the uterine cavity can be kept for a long time, and the ascending infection probability is reduced until the intima is completely repaired (2-3 months).
EXAMPLE III
As shown in fig. 1 and 3, the drug injection tube 31 and the drainage tube 32 are both flexible and stretchable tubes, the drug injection tube 31 and the drainage tube 32 are respectively sleeved on the first branch tube 11 and the second branch tube 12, the tube diameter of the first branch tube 11 is slightly larger than that of the drug injection tube 31, and the tube diameter of the second branch tube 12 is slightly larger than that of the drainage tube 32. The outer sides of the first branch pipe 11 and the second branch pipe 12 are provided with anti-skid lugs 13. The straight line sections and the elastic sections of the first branch pipe 11 and the second branch pipe 12 are elastic structures made of elastic materials.
During the installation, the straightway outside of first branch pipe 11 and second branch pipe 12 is equipped with skid proof block 13, because first branch pipe and second branch pipe 12 are the elasticity branch pipe, consequently, during the installation, at first pull the outside with 11 straightways of first branch pipe, make first branch pipe 11 and 12 straightways of second branch pipe below produce the interval, through the interval with injection pipe 31 open-top outwards tensile, enlarge behind its pipe diameter, the cover is established on first branch pipe 11, and injection pipe 31's top cover establishes skid proof block 13 top, skid proof block 13 prevents injection pipe 31 along 11 landing downwards of first branch pipe. Similarly, the draft tube 32 is installed in the same manner.
The device can also adopt a second installation mode, namely, the drug injection tube 31 and the drainage tube 32 are respectively sleeved on the straight line sections of the first branch tube 11 and the second branch tube 12, the straight line sections at the bottoms of the first branch tube 11 and the second branch tube 12 are connected, and after the first branch tube 11 and the second branch tube 12 are connected in a Y-shaped uterus type structure, the diaphragm 2 is erected between the first support 11 and the second support 12.
According to the invention, the medicine injection pipe 31 and the drainage pipe 32 are respectively and directly sleeved on the first support 11 and the second support 12, the installation is convenient, the pipe diameters of the medicine injection pipe 31 and the drainage pipe 32 are smaller than those of the branch pipes, the medicine injection pipe and the drainage pipe are prevented from falling off from the branch pipes, the connecting force between the pipelines is further improved by arranging the anti-skidding lugs 13 on the branch pipes, and the connecting pipelines are placed to mutually fall off, so that the use effect is influenced.
Example four
On the basis of the above embodiment, the near-opening ends of the first support 11 and the second support 12 are both in an arc-shaped bent shape, and the bottom ends of the first support 11 and the second support 12 are connected to form an included angle of 30-60 degrees. The bottom ends of the first support 11 and the second support 12 are set to be in arc-shaped bent shapes, so that the open ends of the first support 11 and the second support 12 are prevented from being directly contacted with the inner wall of the uterine cavity and the inner wall of the uterine cavity is prevented from being damaged by the corners of the open ends.
The specification also discloses a method for using the anti-adhesion tension-free uterine cavity conformable barrier, which is characterized by comprising the following steps:
(1) examining and evaluating the coronal plane of the uterine cavity before operation, and selecting a uterine cavity bracket with a proper size;
(2) after the hysteroscope intrauterine adhesion separation operation, sufficient hemostasis is realized, the hysteroscope bracket is closed by using a clamp, and the hysteroscope bracket naturally bounces open after passing through an inner opening to form a uterine shape;
(3) injecting anti-adhesion biological glue medicine into the connecting pipeline, discharging liquid through the connecting pipeline after half an hour, observing the liquid discharged from the uterine cavity and the bleeding condition, and keeping the observation for 7 days after the operation;
(4) exposing the cervix after 7 days, cutting off the catheter from the external opening of the cervix after pulling the connecting pipeline, retracting the catheter at the residual end into the cervix, and continuously keeping for 1-3 months;
(5) during hysteroscopy, the bottom of the uterine cavity support is clamped by an intravascular self-cervical tube inner clamp, the uterine cavity support is pulled and taken out, and then the hysteroscopy is carried out.
The using method is simple to use and convenient to operate, does not need special cervical preparation and cervical over-dilation before operation, and does not cause damage to the cervix or the uterine cavity.
The above embodiments are only used to illustrate the technical solution of the present invention, and not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it should be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention in its corresponding aspects.
Claims (9)
1. An anti-adhesion tension-free uterine cavity conformable barrier is characterized in that: including palace chamber support and diaphragm, palace chamber support includes first support and second support, first support with the second support all includes vertical section and elasticity section, and under the natural state, vertical section and elasticity section are certain contained angle, and the palace chamber support that first support and second support formed is the Y form, the diaphragm is filled between two elasticity sections, and under the exogenic action, two elasticity section butts form columnar structure with two vertical sections.
2. The anti-adhesion tensionless uterine cavity conformable barrier according to claim 1, characterized in that: the uterine cavity supporting frame is characterized by further comprising a connecting pipeline, the connecting pipeline is arranged at the bottom of the uterine cavity supporting frame, the first supporting frame and the second supporting frame are of internal hollow structures, and the connecting pipeline is communicated with inner cavities of the first supporting frame and the second supporting frame.
3. The anti-adhesion tensionless uterine cavity conformable barrier according to claim 2, characterized in that: the first support and the second support are two tubular structures which are not communicated with each other, the connecting pipeline comprises a medicine injection pipe and a drainage pipe, the medicine injection pipe is communicated with the inner cavity of the first support, and the drainage pipe is communicated with the inner cavity of the second support.
4. The anti-adhesion tensionless uterine cavity conformable barrier according to claim 3, wherein the top ends of the first support and the first support are both provided with openings, the outer side wall of the first support is provided with a plurality of liquid medicine ports, and the outer side wall of the second support is provided with a plurality of drainage liquid ports.
5. The adhesion-preventing tensionless uterine cavity conformable barrier according to claim 3, wherein control valves are provided on the drug injection tube and the drainage tube, and the bottoms of the drug injection tube and the drainage tube are connected with a syringe or a drainage bag.
6. The adhesion-preventing tensionless uterine cavity conformable barrier according to claim 3, wherein said drug injection tube and said drainage tube are both flexible stretchable tubes, said drug injection tube and said drainage tube are respectively sleeved on the straight line segment of the first branch tube and the straight line segment of the second branch tube, the diameter of said first branch tube is slightly larger than the diameter of said drug injection tube, and the diameter of said second branch tube is slightly larger than the diameter of said drainage tube.
7. The adhesion-preventing tension-free uterine cavity conformable barrier according to claim 6, wherein anti-skid bumps are provided on the outer sides of the straight sections of the first and second branch tubes, and the drug injection tube and the drainage tube are sleeved on the anti-skid bumps.
8. The adhesion-preventing tensionless uterine cavity conformable barrier according to claim 1, wherein the top ends of said first and second brackets are both arc-shaped curved shape, and the bottom ends of said first and second brackets are connected to form an included angle of 30-60 degrees.
9. The anti-adhesion tensionless uterine cavity conformable barrier according to claim 1, wherein said membrane is a non-absorbable latex film or an absorbable biological film, said membrane matches with the internal shape of the uterine cavity stent, and both sides of said membrane are clamped in two branch tubes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921644391.5U CN211156149U (en) | 2019-09-29 | 2019-09-29 | Anti-adhesion tension-free uterine cavity conformal barrier |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921644391.5U CN211156149U (en) | 2019-09-29 | 2019-09-29 | Anti-adhesion tension-free uterine cavity conformal barrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN211156149U true CN211156149U (en) | 2020-08-04 |
Family
ID=71814547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201921644391.5U Withdrawn - After Issue CN211156149U (en) | 2019-09-29 | 2019-09-29 | Anti-adhesion tension-free uterine cavity conformal barrier |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN211156149U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110559061A (en) * | 2019-09-29 | 2019-12-13 | 安徽创孚医疗科技有限公司 | anti-adhesion tension-free uterine cavity conformable barrier and using method thereof |
-
2019
- 2019-09-29 CN CN201921644391.5U patent/CN211156149U/en not_active Withdrawn - After Issue
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110559061A (en) * | 2019-09-29 | 2019-12-13 | 安徽创孚医疗科技有限公司 | anti-adhesion tension-free uterine cavity conformable barrier and using method thereof |
| CN110559061B (en) * | 2019-09-29 | 2024-02-27 | 安徽创孚医疗科技有限公司 | Anti-adhesion Zhang Ligong-cavity-free adaptive barrier and application method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110559061A (en) | anti-adhesion tension-free uterine cavity conformable barrier and using method thereof | |
| JPS5967969A (en) | Cathetel stayed in cervical canal | |
| CN103417272B (en) | Medicine distribution type uterus support | |
| CN102120059A (en) | Medicinal stent-graft for preventing and treating intrauterine adhesion | |
| WO2013108249A1 (en) | Multipurpose catamenial device | |
| US20150238226A1 (en) | Zhukovsky double-balloon obstetric catheter | |
| AU2014214538A1 (en) | Embryo transfer catheter and method | |
| CN105708514A (en) | Device for uterus hemostasis | |
| CN211156149U (en) | Anti-adhesion tension-free uterine cavity conformal barrier | |
| CN109513097A (en) | A kind of two-tube balloon-stent for preventing and treating Asherman's syndrom | |
| CN210472770U (en) | Oviduct radiography and liquid-flowing catheter | |
| CN205612515U (en) | Be used for hemostatic device in uterus | |
| RU2410047C1 (en) | Method of uterine postpartum haemorrhage treatment and double balloon catheter for its implementation | |
| CN202044643U (en) | Drug membrane-covered stent for preventing and curing intrauterine adhesion | |
| CN202859897U (en) | Cervical conformal packing and injecting device | |
| CN209789936U (en) | Anal canal rectum hemostasis drainage tube | |
| CN204951913U (en) | Anti -drop sacculus uterus support | |
| CN217430094U (en) | Multipurpose adjustable vagina packing and fixing device | |
| RU2525533C1 (en) | Method of treatment and prevention of recurrences of intrauterine synechiae | |
| CN206660278U (en) | A kind of Dual-chamber saccular hysterography water service pipe | |
| CN203539420U (en) | Medicine distribution type uterus support | |
| CN106491175A (en) | Sexual oppression uterine cavity hemostasis administration capsule band | |
| CN221654505U (en) | Anti-blocking anti-adhesion uterine cavity balloon device | |
| CN208838260U (en) | A kind of uterus prevents adhesion bracket | |
| CN221787848U (en) | Uterus support with hydrophilic coating |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| AV01 | Patent right actively abandoned | ||
| AV01 | Patent right actively abandoned | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20200804 Effective date of abandoning: 20240227 |
|
| AV01 | Patent right actively abandoned |
Granted publication date: 20200804 Effective date of abandoning: 20240227 |